Latest Investor Confidence News

Omni Bridgeway reports strong investment activity and a robust pipeline for Q3 2026, maintaining solid returns and cost discipline amid global market volatility.

BlinkLab has completed onboarding all clinical sites for its pivotal FDA autism trial, enrolled the first participant, and launched a nationwide autism screening program in Morocco. A recent A$17.7 million capital raise will fund further trials and expansion into ADHD diagnostics.

Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.

Toubani Resources has kicked off construction at its Kobada Gold Project in Mali following a positive Final Investment Decision, while securing a US$83.5 million financing package to support development.

Proteomics International is pivoting from research to disciplined commercial execution of its proteomics-based diagnostic tests, focusing on distributor partnerships and reimbursement pathways in Australia and the US.

American Tungsten & Antimony (ASX: AT4) has set up a Level 1 ADR program with Deutsche Bank, paving the way for its planned Nasdaq listing in Q2 2026 and opening U.S. dollar trading access for American investors.

The Federal Court has imposed a $1.55 million penalty on Money3 Loans, a Solvar subsidiary, for limited breaches of the National Consumer Credit Act between 2019 and 2021. Solvar highlights strengthened governance and underwriting since the period in question.

PYC Therapeutics has gained Orphan Drug Designation from the European Medicines Agency for its VP-001 candidate targeting Retinitis Pigmentosa type 11, enhancing its regulatory and commercial pathway in Europe.

Temas Resources has closed a CAD 1.5 million flow-through share placement with Maple Leaf Critical Minerals Fund, reinforcing funding for its Quebec titanium projects and proprietary Regenerative Chloride Leach technology commercialisation.

Papyrus Australia (ASX: PPY) has secured $175,000 through a share placement alongside convertible note conversions and related party loans, aiming to fund commercialisation and fulfil a key contract for biodegradable Collar Keeper® products.

Light & Wonder has been hit with a class action lawsuit in Victoria alleging misleading statements about its Dragon Train game, targeting shareholders who bought Chess Depositary Interests between May 2023 and September 2024. The company has pledged a vigorous defence amid ongoing legal challenges.

Metro Mining has secured shareholder approval for a 1-for-20 share consolidation, cutting its shares on issue from over 6.1 billion to roughly 307 million. The move aims to streamline the capital structure and attract broader investor interest.